Search

Search Constraints

You searched for: Author/Creator Rubbert-Roth, Andrea

Search Results

2. A randomised phase IIb study of mavrilimumab, a novel GM–CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritis. Issue 6 (17th February 2017)

3. A randomised, double-blind, parallel-group study of the safety and efficacy of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with moderate to severe rheumatoid arthritis (SUMMACTA study). Issue 1 (31st July 2013)

4. AB0277 EFFECT OF DISEASE DURATION AND OTHER PATIENT BASELINE CHARACTERISTICS ON OUTCOMES IN TOCILIZUMAB-TREATED RHEUMATOID ARTHRITIS PATIENTS: A POOLED ANALYSIS. (June 2019)

5. AB0610 PERSISTENT INFLAMMATION DESPITE TOCILIZUMAB TREATMENT IN 2 PATIENTS WITH LARGE VESSEL VASCULITIS AND AORTIC INVOLVEMENT REQUIRING AORTIC VALVE REPLACEMENT. (June 2019)

8. Antigen-presenting human B cells are expanded in inflammatory conditions. Issue 2 (17th August 2016)

9. Associations between serum antibodies to periodontal pathogens and preclinical phases of rheumatoid arthritis. (29th January 2021)

10. Canakinumab for Treatment of Adult-Onset Still's Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial. Issue 8 (13th May 2020)